Alenson Carman 4
4 · Prime Medicine, Inc. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Alenson Carman
See Remarks
Transactions
- Award
Stock Option (right to buy)
2025-02-27+90,500→ 90,500 totalExercise: $2.42Exp: 2035-02-27→ Common Stock (90,500 underlying)
Footnotes (1)
- [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 27, 2025, subject to the Reporting Person's continued service on each such vesting date.